Skip to main content
. 2018 Feb 2;9(38):25025–25033. doi: 10.18632/oncotarget.24382

Table 4. Age-specific penetrance of ovarian cancer (× 100) by BRCA1 and BRCA2 mutation status, estimated using data from the first-degree relatives by the modified kin-cohort method.

BRCA1 carrier BRCA2 carrier Non-carrier
Age Interval Penetrance (%) (95% CI) Penetrance (%) (95% CI) Penetrance (%) (95% CI)
30-50 years 5.0 (1.8-13.3) - 0.4 (0.2-0.6)
30-60 years 13.7 (6.6-24.3) 1.31 0.7 (0.4-1.0)
30-70 years 21.5 (10.4-37.1) 7.31 1.4 (0.9-1.9)

1Number of events too small to allow for reasonable estimates of confidence intervals.